5-HT1-receptor agonists are potent, long acting agents that lower arterial pressure and induce bradycardia in cats, dogs, and rats. 8-OH-2-di-n propylaminotetralin (8-OH DPAT) will serve as the reference chemical and will be compared with newly-synthesized apomorphine derivatives in which the 10-OH group is substituted with CH3, CH2OH, H, etc., as well as altering substitution on nitrogen (aporphines). Preliminary studies ahve demonstrated that the 10-CH3, N-CH3 aporphine derivative parallels closely the behavorial and cardiovascular changes-induced by 8-OH DPAT, a selective 5-HT1A receptor agonist. The aporphine compound has no interaction with DA2-receptors and our hypothesis is that alkyl substitutions in the 10-position of apomorphine introduce potent 5-HT1-receptor agonist properties. The experimental procedures will evaluate possible central and peripheral sites for the hypotensive and bradycardic responses induced by these series of compounds, investigate reflex activations of the sympathetic and parasympathetic nervous systems, and determine receptor selectively and specificity using various radioligand binding and bioassay procedures. Direct goals of this research include: (1) determine the role of 5- HT1 -receptors for control of the cardiovascular system, (2) evaluate present hypothesis is that these agents are potent 5-HT- receptor agonists, and both of these series of agents are very potent in blocking cardiovascular responses to bilateral carotid occlusion, inducing bradycardia and hypotension, (3) identifying agonists for serotonin-receptor subtypes; this is certainly needed to help define physiological roles of this receptor, and (4) since we have no selective antagonists for 5-HT1 receptors, an active agent is clearly needed and this research will identify antagonists for 5-HT1 receptor subtypes. This research will combine chemical and biological experimental procedures to advance our understanding of the role of 5-HT1 receptors in cardiovascular pharmacology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL038136-02
Application #
3354187
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1987-04-01
Project End
1990-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Ma, S; Long, J P (1993) Hypotensive and bradycardiac responses to reflex sympathetic inhibition produced by nitroglycerin in rats with sinoaortic deafferentation. J Cardiovasc Pharmacol 21:136-43
Ma, S; Long, J P; Bhatnagar, R K (1992) Further studies on central actions of nitroglycerin and lack of evidence for nitroglycerin interacting on [3H]clonidine binding sites in cortex membranes. J Pharmacol Exp Ther 261:1187-94
Ma, S; Long, J P (1992) Central noradrenergic activity and the cardiovascular effects of nitroglycerin and amyl nitrate. J Cardiovasc Pharmacol 20:826-36
Ma, S X; Long, J P (1991) Effects of nitroglycerin on release, synthesis and metabolism of norepinephrine and activation of tyrosine hydroxylase in guinea-pigs. Eur J Pharmacol 199:27-33
Park, K H; Long, J P; Cannon, J G (1991) Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists. J Pharmacol Exp Ther 259:1221-30
Ma, S X; Long, J P (1991) Central noradrenergic activity is responsible for nitroglycerin-induced cardiovascular effects in the nucleus tractus solitarii. Brain Res 559:297-303
Park, K H; Long, J P; Cannon, J G (1991) Effects of serotonin1-like receptor agonists on autonomic neurotransmission. Can J Physiol Pharmacol 69:1855-60
Park, K H; Long, J P (1991) Modulation by physostigmine of head-up tilt- and bilateral carotid occlusion-induced baroreflexes in rats. J Pharmacol Exp Ther 257:50-5
Ma, S X; Long, J P; Flynn, J R et al. (1991) Dopaminergic structure-activity relationships of 2-aminoindans and cardiovascular action and dopaminergic activity of 4-hydroxy, 5-methyl, 2-di-n-propylaminoindan (RD-211). J Pharmacol Exp Ther 256:751-6
Ma, S X; Long, J P (1991) Positive chronotropic and inotropic responses to release of norepinephrine from sympathetic nerve terminals produced by nitroglycerin in atria. Arch Int Pharmacodyn Ther 309:125-36

Showing the most recent 10 out of 12 publications